Skip to content

BRonchoscopic Evaluation after Atrial fibrillation cryo-THErapy

BRonchoscopic Evaluation after Atrial fibrillation cryo-THErapy - BEST BREATHE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011273
Enrollment
30
Registered
2016-11-02
Start date
2016-11-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial lesion after cryo-ablation

Interventions

Group 1: Process Flow: If a patient is planned for manually performed pulmonary vein isolation using cryo energy, this is checked for our inclusion and exclusion criteria. In the case of missing excl

Sponsors

Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Both women (after exclusion of a pregnancy) and men older than 18 years are included, with planned manual guided pulmonary vein isolation using cryo-energy. There must be no contraindications for anticoagulation. Admission to study participation is required.

Exclusion criteria

Exclusion criteria: Catheter ablation within 3 months before the planned pulmonary vein isolation using cryo-energy. Pneumonia within 3 months prior to ablation. Patients with a COPD Gold III-IV or a known change in the bronchial system. Patients with known or impaired pulmonary malignancy. Existing contraindication to perform bronchoscopy.

Design outcomes

Primary

MeasureTime frame
Incidence of Bronchial lesions after Cryoablation.

Secondary

MeasureTime frame
Classification of the bronchial lesions by severity. Temperature profile during cooling and influence on the incidence of bronchial lesions. Thawing behavior of the cryoballon and influence on the incidence of bronchial lesions. Effect of the temperature profile of the routinely used esophageal temperature probe on the incidence of bronchial lesions.

Countries

Germany

Contacts

Public ContactBarbara Bellmann

Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin

barbarabellmann@charite.de030450513847

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026